全球花生油酸市场－2026-2031年预测

全球花生油酸市场预计将从 2025 年的 274,543,000 美元成长到 2031 年的 354,962,000 美元，复合年增长率为 4.37%。

花生油酸(ARA) 是一种长链ω-6多元多不饱和脂肪酸(20:4 n-6)，在婴幼儿营养和运动营养补充剂这两个高价值领域中仍然是一种重要的功能性成分。作为细胞膜的主要结构成分，特别是在神经、视网膜、免疫和骨骼肌组织中，ARA 在早期发育和严重生理压力条件下是一种条件必需脂肪酸。市售 ARA 主要透过控制产油真菌高山毛霉 (Mortierella alpinee) 的发酵生产，得到一种含有 40-50% ARA 的单细胞油，然后进行提纯和标准化处理。

主要成长要素

1.花生油酸(ARA) 与二十二碳六烯酸 (DHA) 联合使用，经监管部门核准并标准化后，已成为全球高端婴儿配方奶粉和较大婴儿配方奶粉的标准成分。欧盟法规明确授权使用源自高山毛霉 (Mortierella alpina) 的奶粉作为婴儿奶粉、较大婴儿配方奶粉和某些特殊医学用途食品中的 ARA 来源。越来越多的科学共识表明 ARA 在早期神经发育和免疫成熟中发挥着重要作用，这持续推动着已开发市场和新兴市场对 ARA 的需求不断增长。

2. 运动营养和表现的扩展：受控临床试验表明，ARA 能够促进瘦体重增加、峰值功率输出和训练引起的合成代谢信号，这使其成为力量和爆发力类别中的一种差异化成分，尤其受到寻求非激素增效剂的阻力训练者的需求。

3. 微生物油生产的持续创新。主要生产商（BASF、CABIO、透过原嘉吉/武汉伙伴关係的帝斯曼以及湖北復兴生物技术有限公司）不断提高发酵产量、油纯度和永续性指标，确保高纯度ARA油的稳定供应和具有竞争力的价格。

区域趋势

北美市场持续维持主导，主要原因如下：

• 优质婴儿奶粉人均消费量高
• 积极的研发活动已获得多项与ARA在婴幼儿营养和运动表现领域应用相关的专利。
• 运动营养在力量型运动员中的快速发展
• 墨西哥出生率上升以及美国婴儿奶粉市场持续扩大

欧洲的成长速度仅次于北美，位居第二，这主要得益于监管部门的明确批准以及消费者对强化婴幼儿营养品的强劲信心。亚太地区的销售成长速度最快，这主要得益于中国、印度和东南亚中产阶级对高端婴幼儿奶粉的需求不断增长，以及新兴运动营养品类的成长。

花生油酸市场持续受益于其双重角色：既是婴幼儿必需营养素，也是成人运动表现增强补充剂。随着高山毛霉油的成熟、规模化生产和监管已通过核准，花生四烯酸的供应限制已解除。预计市场成长将持续，这得益于婴幼儿营养品的优质化、消费者对针对性运动补充剂的接受度不断提高，以及花生四烯酸在女性健康和临床营养领域应用潜力的拓展——在这些领域，花生四烯酸在细胞膜流动性和类花生酸信号传导中的作用具有显着优势。

本报告的主要优势：

• 深入分析：取得以客户群、政府政策和社会经济因素、消费者偏好、垂直产业和其他细分市场为重点的深入市场洞察，涵盖主要地区和新兴地区。
• 竞争格局：了解主要企业采取的策略倡议，并了解透过正确的策略打入市场的潜力。
• 市场驱动因素与未来趋势：探索动态因素和关键市场趋势，以及它们将如何塑造未来的市场发展。
• 可执行的建议：利用洞察力为策略决策提供讯息，从而在动态环境中开拓新的业务管道和收入来源。
• 受众范围广：对新兴企业、研究机构、顾问公司、中小企业和大型企业都有益处且经济高效。

它是用来做什么的？

产业与市场洞察、商业机会评估、产品需求预测、打入市场策略、地理扩张、资本投资决策、法律规范及影响、新产品开发、竞争影响

分析范围

• 历史资料（2021-2025 年）和预测资料（2026-2031 年）
• 成长机会、挑战、供应链前景、法规结构、客户行为和趋势分析
• 竞争对手定位、策略和市场占有率分析
• 按业务板块和地区（国家）分類的收入成长和预测分析
• 公司概况（策略、产品、财务资讯、关键趋势等）

目录

第一章执行摘要

第二章市场概述

• 市场概览
• 市场定义
• 分析范围
• 市场区隔

第三章 商业情境

• 市场驱动因素
• 市场限制
• 市场机会
• 波特五力分析
• 产业价值链分析
• 政策和法规
• 策略建议

第四章 技术展望

5. 全球花生油酸市场（按原始材料类型划分）

• 介绍
• 动物源性
• 植物来源

6. 全球花生油酸市场（依形态划分）

• 介绍
• 烘干
• 液体

7. 全球花生油酸市场依应用领域划分

• 介绍
• 婴幼儿营养食品
• 营养补充品
• 製药
• 其他的

8. 全球花生油酸市场（按地区划分）

• 介绍
• 北美洲
  • 我们
  • 加拿大
  • 墨西哥
• 南美洲
  • 巴西
  • 阿根廷
  • 其他的
• 欧洲
  • 德国
  • 法国
  • 英国
  • 西班牙
  • 其他的
• 中东和非洲
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 以色列
  • 其他的
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 印尼
  • 泰国
  • 其他的

第九章：竞争格局与分析

• 主要企业和策略分析
• 市占率分析
• 企业合併、协议、商业合作
• 竞争对手仪錶板

第十章：公司简介

• Cargill Incorporated
• Cabio Biotech（Wuhan）Co.., Ltd
• Cayman Chemicals
• DSM-Firmenich
• Merck KgaA
• Avanti Research（Croda International Plc.）
• Guangdong Runke Bioengineering Co., Ltd
• Bio-Techne Corporation
• HiMedia Laboratories LLC
• Tokyo Chemical Industry

第十一章附录

• 货币
• 先决条件
• 基准年和预测年时间表
• 相关人员的主要收益
• 分析方法
• 简称

Global Arachidonic Acid Market is expected to grow at a 4.37% CAGR, increasing to USD 354.962 million in 2031 from USD 274.543 million in 2025.

Arachidonic acid (ARA), a long-chain omega-6 polyunsaturated fatty acid (20:4 n-6), remains a critical functional ingredient in two high-value segments: infant nutrition and sports performance supplementation. As a key structural component of cell membranes, particularly in neural, retinal, immune, and skeletal muscle tissues, ARA is conditionally essential during early development and periods of intense physical stress. Commercial ARA is predominantly produced via controlled fermentation of the oleaginous fungus Mortierella alpina, yielding single-cell oils containing 40-50 % ARA that are subsequently refined and standardized.

Primary Growth Drivers

1. Regulatory acceptance and standardization in infant nutrition ARA, in combination with docosahexaenoic acid (DHA), is now a standard addition to premium infant and follow-on formulas worldwide. EU legislation explicitly authorizes oil derived from Mortierella alpina as a source of ARA for infant formula, follow-on formula, and foods for special medical purposes. Growing scientific consensus on the role of ARA in early neurodevelopment and immune maturation continues to drive inclusion rates in both developed and emerging markets.

2. Expanding sports nutrition and performance segment Controlled clinical studies demonstrating ARA's ability to support lean mass gains, peak power output, and training-induced anabolic signaling have established it as a differentiated ingredient in the strength and power athlete category. Demand is particularly strong among resistance-trained individuals seeking non-hormonal ergogenic aids.

3. Sustained innovation in microbial oil production Leading producers (BASF, CABIO, DSM via the former Cargill/Wuhan partnership, and Hubei Fuxing Biotechnology) continue to improve fermentation yields, oil purity, and sustainability metrics, ensuring stable supply and competitive pricing for high-purity ARA oils.

Regional Dynamics

North America maintains market leadership through a combination of:

• High per-capita consumption of premium infant formula
• Intense R&D activity resulting in numerous patents for ARA applications in early-life nutrition and sports performance
• Rapidly growing sports nutrition sector targeting strength athletes
• Rising fertility rates in Mexico and continued premiumization of the U.S. infant formula market

Europe follows closely, supported by clear regulatory authorization and strong consumer trust in fortified infant nutrition. Asia-Pacific exhibits the fastest unit growth, driven by expanding middle-class demand for premium infant formula in China, India, and Southeast Asia, alongside emerging sports nutrition categories.

The arachidonic acid market continues to benefit from its dual role as both an essential early-life nutrient and a performance-enhancing supplement for adults. With Mortierella alpina-derived oils now representing a mature, scalable, and regulator-approved source, ARA supply is no longer a constraint. Growth will be sustained by ongoing premiumization of infant nutrition, increasing consumer acceptance of targeted sports supplements, and potential pipeline extensions into women's health and clinical nutrition applications where ARA's role in membrane fluidity and eicosanoid signaling offers differentiated benefits.

Key Benefits of this Report:

• Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
• Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
• Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
• Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
• Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

• Historical data from 2021 to 2025 & forecast data from 2026 to 2031
• Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
• Competitive Positioning, Strategies, and Market Share Analysis
• Revenue Growth and Forecast Assessment of segments and regions including countries
• Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Arachidonic Acid Market Segmentation:

• By Source Type
• Animal-Based
• Plant-Based
• By Form Type
• Dry
• Liquid
• By Application
• Infant Nutrition
• Dietary Supplements
• Pharmaceuticals
• Others
• By Geography
• North America
• USA
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• Germany
• France
• United Kingdom
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• China
• India
• Japan
• South Korea
• Indonesia
• Thailand
• Others

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

• 2.1. Market Overview
• 2.2. Market Definition
• 2.3. Scope of the Study
• 2.4. Market Segmentation

3. BUSINESS LANDSCAPE

• 3.1. Market Drivers
• 3.2. Market Restraints
• 3.3. Market Opportunities
• 3.4. Porter's Five Forces Analysis
• 3.5. Industry Value Chain Analysis
• 3.6. Policies and Regulations
• 3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL ARACHIDONIC ACID MARKET BY SOURCE TYPE

• 5.1. Introduction
• 5.2. Animal-Based
• 5.3. Plant-Based

6. GLOBAL ARACHIDONIC ACID MARKET BY FORM TYPE

• 6.1. Introduction
• 6.2. Dry
• 6.3. Liquid

7. GLOBAL ARACHIDONIC ACID MARKET BY APPLICATION

• 7.1. Introduction
• 7.2. Infant Nutrition
• 7.3. Dietary Supplements
• 7.4. Pharmaceuticals
• 7.5. Others

8. GLOBAL ARACHIDONIC ACID MARKET BY GEOGRAPHY

• 8.1. Introduction
• 8.2. North America
  • 8.2.1. USA
  • 8.2.2. Canada
  • 8.2.3. Mexico
• 8.3. South America
  • 8.3.1. Brazil
  • 8.3.2. Argentina
  • 8.3.3. Others
• 8.4. Europe
  • 8.4.1. Germany
  • 8.4.2. France
  • 8.4.3. United Kingdom
  • 8.4.4. Spain
  • 8.4.5. Others
• 8.5. Middle East and Africa
  • 8.5.1. Saudi Arabia
  • 8.5.2. UAE
  • 8.5.3. Israel
  • 8.5.4. Others
• 8.6. Asia Pacific
  • 8.6.1. China
  • 8.6.2. India
  • 8.6.3. Japan
  • 8.6.4. South Korea
  • 8.6.5. Indonesia
  • 8.6.6. Thailand
  • 8.6.7. Others

9. COMPETITIVE ENVIRONMENT AND ANALYSIS

• 9.1. Major Players and Strategy Analysis
• 9.2. Market Share Analysis
• 9.3. Mergers, Acquisitions, Agreements, and Collaborations
• 9.4. Competitive Dashboard

10. COMPANY PROFILES

• 10.1. Cargill Incorporated
• 10.2. Cabio Biotech (Wuhan) Co.., Ltd
• 10.3. Cayman Chemicals
• 10.4. DSM-Firmenich
• 10.5. Merck KgaA
• 10.6. Avanti Research (Croda International Plc.)
• 10.7. Guangdong Runke Bioengineering Co., Ltd
• 10.8. Bio-Techne Corporation
• 10.9. HiMedia Laboratories LLC
• 10.10. Tokyo Chemical Industry

11. APPENDIX

• 11.1. Currency
• 11.2. Assumptions
• 11.3. Base and Forecast Years Timeline
• 11.4. Key Benefits for the Stakeholders
• 11.5. Research Methodology
• 11.6. Abbreviations